Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Restoration of Nusinersen Levels Following Treatment Interruption in People With Spinal Muscular Atrophy: Simulations Based on a Population Pharmacokinetic Model. | CNS Drugs | 2022 | 35080757 | PubTator, text mining | PubMed |
| RNA-based therapeutics for neurological diseases. | RNA Biol | 2022 | 35067193 | PubTator, text mining | PubMed |
| Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid. | Clin Pharmacol Ther | 2022 | 35064573 | PubTator, text mining | PubMed |
| Natural history of 10-meter walk/run test performance in spinal muscular atrophy: A longitudinal analysis. | Neuromuscul Disord | 2022 | 35063329 | PubTator, text mining | PubMed |
| Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders. | Biomedicines | 2022 | 35052837 | PubTator, text mining | PubMed |
| Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders. | Genes (Basel) | 2022 | 35052449 | PubTator, text mining | PubMed |
| Body mass index in type 2 spinal muscular atrophy: a longitudinal study. | Eur J Pediatr | 2022 | 35048179 | PubTator, text mining | PubMed |
| [Precision medicine in pediatric neurology exemplified by the new treatment forms]. | Nervenarzt | 2022 | 35037966 | PubTator, text mining | PubMed |
| Managing pregnancy in a spinal muscular atrophy type III patient in Indonesia: a case report. | J Med Case Rep | 2022 | 35033190 | PubTator, text mining | PubMed |
| Systematic characterization of short intronic splicing-regulatory elements in SMN2 pre-mRNA. | Nucleic Acids Res | 2022 | 35018432 | PubTator, text mining | PubMed |
| Non-viral vectors for RNA delivery. | J Control Release | 2022 | 35016918 | PubTator, text mining | PubMed |
| Case report of pregnancy management and genetic evaluation after negative carrier screening for spinal muscular atrophy in an affected family. | Case Rep Womens Health | 2022 | 35004188 | PubTator, text mining | PubMed |
| Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study. | Rev Neurol (Paris) | 2022 | 35000792 | PubTator, text mining | PubMed |
| Next generation sequencing is a highly reliable method to analyze exon 7 deletion of survival motor neuron 1 (SMN1) gene. | Sci Rep | 2022 | 34997153 | PubTator, text mining | PubMed |
| Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders. | Neurol Res Pract | 2022 | 34983696 | PubTator, text mining | PubMed |
| Ethical Perspectives on Treatment Options with Spinal Muscular Atrophy Patients. | Ann Neurol | 2022 | 34981567 | PubTator, text mining | PubMed |
| Clinical efficiency of simultaneous CNV-seq and whole-exome sequencing for testing fetal structural anomalies. | J Transl Med | 2022 | 34980134 | PubTator, text mining | PubMed |
| Reexamining assumptions about miRNA-guided gene silencing. | Nucleic Acids Res | 2022 | 34967419 | PubTator, text mining | PubMed |
| Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs. | J Manag Care Spec Pharm | 2022 | 34949120 | PubTator, text mining | PubMed |
| Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. | Lancet Neurol | 2022 | 34942136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=53